Scenario name,Rate of gonorrhea cases,"% cases successfully treated with CIP, TET, or CRO",% cases successfully treated with CIP,% cases successfully treated with TET,% cases successfully treated with CRO,"Effective lifespan of CIP, TET, and CRO",Effective lifespan of CIP,Effective lifespan of TET,Effective lifespan of CRO,delta - Rate of gonorrhea cases,"delta - Effective lifespan of CIP, TET, and CRO",delta - Effective lifespan of CIP,delta - Effective lifespan of TET,delta - Effective lifespan of CRO
Status quo (no rapid test),"7,086 (5,723, 8,013)","53.3% (38.6%, 67.0%)","0.0% (0.0%, 0.0%)","0.0% (0.0%, 0.0%)","53.3% (38.6%, 67.0%)","13.3 (9.6, 16.7)","0.0 (0.0, 0.0)","0.0 (0.0, 0.0)","13.3 (9.6, 16.7)",,,,,
"(p=(0.980, 0.750), q=(0.980, 0.975), c=0.500)","7,256 (5,876, 8,204)","65.1% (45.7%, 83.6%)","20.0% (12.1%, 27.0%)","1.9% (1.3%, 2.8%)","43.2% (31.7%, 54.8%)","16.3 (11.4, 20.9)","5.0 (3.0, 6.8)","0.5 (0.3, 0.7)","10.8 (7.9, 13.7)","2.4% (1.2%, 4.6%)","22.3% (4.5%, 39.0%)","nan% (nan%, nan%)","nan% (nan%, nan%)","-18.6% (-29.5%, -7.2%)"
"(p=(0.980, 0.750), q=(0.980, 0.975), c=0.750)","7,388 (6,021, 8,360)","66.0% (49.5%, 84.5%)","30.2% (18.8%, 40.8%)","2.8% (2.0%, 4.2%)","33.0% (26.9%, 41.2%)","16.5 (12.4, 21.1)","7.5 (4.7, 10.2)","0.7 (0.5, 1.0)","8.3 (6.7, 10.3)","4.3% (2.4%, 6.7%)","24.4% (5.8%, 37.3%)","nan% (nan%, nan%)","nan% (nan%, nan%)","-37.4% (-46.1%, -27.7%)"
"(p=(0.980, 0.750), q=(0.980, 0.975), c=1.000)","7,527 (6,061, 8,485)","66.7% (51.9%, 88.5%)","40.4% (26.9%, 56.8%)","3.7% (2.6%, 5.7%)","22.6% (17.5%, 29.4%)","16.7 (13.0, 22.1)","10.1 (6.7, 14.2)","0.9 (0.6, 1.4)","5.7 (4.4, 7.3)","6.2% (3.9%, 9.2%)","25.9% (9.8%, 43.9%)","nan% (nan%, nan%)","nan% (nan%, nan%)","-56.7% (-68.0%, -41.7%)"
